The liquid formula, extracted from a compound in marijuana that doesn't cause euphoric effects, would be the first government-approved drug derived from the cannabis plant in the U.S.
from Kaiser Health News https://ift.tt/2JUPczr
April 18, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Survey Suggests Disconnect Between What Physicians Expect When New Drugs Are Approved, And What FDA Actually Requires"It matters because physicians use prescribed drugs on the presumption they have been adequately tested and rely on FDA approval," said Dr. Aaron Kesselheim, a co-author of the research. "They feel comfortable that a group of… Read More
Opioid Crisis In Court: Sackler Family Made Billions Off OxyContin; Sales Rep Says Insys Used Speaker Gigs As Bribes; Nationwide Lawsuit Heats Up In OhioWith the opioid epidemic in full swing, many have turned to the courts to demand drug companies be held responsible for their alleged role in the crisis. In the high-profile lawsuits unfolding: Unredacted documents provide mo… Read More
Ferocious Trade Secrets Showdown Between UnitedHealth, Gawande-Led Initiative Hints At Broader Fight Over Future Of IndustryTech giants like Amazon, Apple and Google are all trying to shoulder into the health field, and the companies that are already struggling in a tough landscape do not welcome new competition. The trade secrets lawsuit fight be… Read More
Health Law 2019 Sees Big Plunge Among New Enrollees In California While Overall Enrollment HoldsThe federal decision to drop the mandate might be why there was a greater-than-expected dropoff, officials said. California is considering adding a state mandate. Other news on the health law looks at the decline of employer-… Read More
First Edition: January 31, 2019Note to readers: If you are in the D.C. area, please join us Thursday, Jan. 31, for a live taping of KHN’s weekly podcast, “What The Health,” hosted by Julie Rovner and her expert panel of health journalists. Registration beg… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment